MHRA Drug Safety Update July 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 12 July 2022) has been published and includes articles on:

  • Topiramate (Topamax): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure
  • COVID-19 vaccines and medicines: updates for July 2022
  • Letters and medicine recalls sent to healthcare professionals in June 2022

To see the latest MHRA Drug Safety Updates in full, visit the website